Abstract:An increasing number of artemisinin (ARS) and its derivatives have been reported for their potential therapeutic value of human cancer. However, their therapeutic potencies are limited owing to their poor pharmacokinetic profiles. Our previous studies showed that a lead compound ARS4 originated from incorporating the pharmacophore of the approved chemotherapeutic agent melphalan into the basic skeleton of artemisinin with a succinic linker exhibited an excellent toxicity to human ovarian cancer cells and low cytotoxicity to normal cells. The mechanism studies demonstrated that it inhibited the growth and proliferation of ovarian cancer cells and resulted in S-phase arrest, apoptosis and inhibition of migration. Meanwhile, it exhibited excellent antitumor activities in animal models. Herein, further structure optimization for this lead compound ARS4 was performed and nineteen novel derivatives were designed and synthesized. Among them, compounds 10-12, 15, 16, 18 and 19 demonstrated powerful cytotoxic effects against human liver cancer and ovarian cancer cell lines, with their IC50s below 0.86 μM against Hep3B and A2780 cell lines, which are superior to that of ARS4. Four compounds (11, 15, 16 and 18) were selected to further evaluate their antitumor activities in in vitro and in vivo ovarian and liver cancer models, the results indicated that compound 18 exhibited the best therapeutic effect, not only effectively inhibited the growth of 7404 xenograft and Huh7 xenograft, but also presented a good dose-dependent inhibition toward the growth of A2780 xenograft. Overall, based on these positive results, these novel chemical structures may provide a new inspiration for the discovery of novel antitumor agents originated from artemisinin scaffolds.

11‐Aza‐artemisinin Derivatives Exhibit Anticancer Activities by Targeting the Fatty Acid Binding Protein 6 (FABP6)

Anti-malarial drug: the emerging role of artemisinin and its derivatives in liver disease treatment

Design of novel artemisinin-like derivatives with cytotoxic and anti-angiogenic properties

Synthesis, Anticancer Evaluation and Pharmacokinetic Study of Novel 10-O-phenyl Ethers of Dihydroartemisinin

[Design, Synthesis and Antiproliferative Activities of Artemisinin Derivatives Substituted by N-heterocycles].

[Design, Synthesis and Antiproliferative Activity in Cancer Cells of Novel Dihydropyrazolyl and Pyrazolyl Artemisinin-Phenyl Ethers].

Design, synthesis, and in vitro and in vivo biological evaluation of dihydroartemisinin derivatives as potent anti-cancer agents with ferroptosis-inducing and apoptosis-activating properties

Biological Activities of Artemisinin Derivatives Beyond Malaria.

Study on the structure-activity relationship of dihydroartemisinin derivatives: Discovery, synthesis, and biological evaluation of dihydroartemisinin-bile acid conjugates as potential anticancer agents

Synthesis and Anti-Tumor Effect of Artemisone Derivatives

Farnesylthiosalicylic Acid Sensitizes Hepatocarcinoma Cells to Artemisinin Derivatives

Artemisinin and Its Derivatives as Potential Anticancer Agents

Structural optimization and biological evaluation for novel artemisinin derivatives against liver and ovarian cancers

Facilitated Drug Repurposing with Artemisinin-Derived PROTACs: Unveiling PCLAF as a Therapeutic Target

Synthesis of N-11-Anchoring Biotinylated Artemisinin Derivatives and Their Preliminary Biological Assessment

Mechanism-Guided Design and Synthesis of a Mitochondria-Targeting Artemisinin Analogue with Enhanced Anticancer Activity.

Synthesis, X-ray Crystal Structure, DFT Calculation and Anti-Tumor Research of Novel-Configurational Dihydroartemisinin Purine Hybrids

Discovery of novel dihydroartemisinin-cinnamic hybrids inducing lung cancer cells apoptosis via inhibition of Akt/Bad signal pathway

Synthesis And Anti-Tumor Activities Of Novel Artemisone-Piperazine-Sulfonamide Derivatives

Synthesis and Cytotoxicity of Novel Artemisinin Derivatives Containing Sulfur Atoms.

Synthesis and in Vitro Antitumor Evaluation of Dihydroartemisinin-Cinnamic Acid Ester Derivatives.